Skip to main content

Breast Cancer Research and Treatment

Ausgabe 2/2018

Inhalt (27 Artikel)

Review

Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis

Angela K. Green, Emeline M. Aviki, Konstantina Matsoukas, Sujata Patil, Deborah Korenstein, Victoria Blinder

Review

Neoadjuvant therapy for breast cancer treatment: an expert panel recommendation from the Brazilian Society of Breast Surgeons 2018

Fernanda Barbosa C Rocha, Ana Beatriz Falcone, Antonio Carlos Buzaid, Juliana Martins Pimenta, Gustavo Schvartsman, Antonio Luiz Frasson

Preclinical study

Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study

Sae Byul Lee, Seung Sang Ko, Chan Heun Park, Seok Jin Nam, Jung Eun Choi, Yong Sik Jung, Woo-Chan Park, Byung Ho Son

Preclinical study

The prognostic value of androgen receptors in breast cancer subtypes

Maria Ryssdal Kraby, Marit Valla, Signe Opdahl, Olav Anton Haugen, Joanna Ewa Sawicka, Monica Jernberg Engstrøm, Anna Mary Bofin

Preclinical study

Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells

Sagar Regmi, To Sing Fung, Sierin Lim, Kathy Qian Luo

Open Access Preclinical study

Co-expressed genes enhance precision of receptor status identification in breast cancer patients

Michael Kenn, Dan Cacsire Castillo-Tong, Christian F. Singer, Michael Cibena, Heinz Kölbl, Wolfgang Schreiner

Open Access Preclinical study

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

Natalie C. Wu, Wendy Wong, Kenneth E. Ho, Victor C. Chu, Annaliza Rizo, Simon Davenport, Devon Kelly, Rosemary Makar, Jacek Jassem, Renata Duchnowska, Wojciech Biernat, Barbara Radecka, Tomoyuki Fujita, Jonathan L. Klein, Mark Stonecypher, Shoichiro Ohta, Hartmut Juhl, Jodi M. Weidler, Michael Bates, Michael F. Press

Preclinical study

Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer

Vahid Bemanian, John Christopher Noone, Torill Sauer, Joel Touma, Katja Vetvik, Cecilia Søderberg-Naucler, Jonas Christoffer Lindstrøm, Ida Rashida Bukholm, Vessela N. Kristensen, Jürgen Geisler

Preclinical study

Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling

Lisa Goto-Yamaguchi, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Yoshitaka Fujiki, Mai Tomiguchi, Aiko Sueta, Takashi Takeshita, Hirotaka Iwase

Open Access Clinical trial

Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer

Bihong T. Chen, Taihao Jin, Sunita K. Patel, Ningrong Ye, Can-Lan Sun, Huiyan Ma, Russell C. Rockne, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan, Daneng Li, George Somlo, Jessica Vazquez, Abrahm Levi, Heidi Tan, Richard Yang, Vani Katheria, Arti Hurria

Clinical trial

Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer

Adrienne E. Borrie, Rhiannon V. Rose, Yun-Hee Choi, Francisco E. Perera, Nancy Read, Tracy Sexton, Michael Lock, Theodore A. Vandenberg, Karin Hahn, Robert Dinniwell, Jawaid Younus, Diane Logan, Kylea Potvin, Brian Yaremko, Edward Yu, John Lenehan, Stephen Welch, Rachel F. Tyndale, Wendy A. Teft, Richard B. Kim

Clinical trial

A comparison of the imaging features of pleomorphic and classical invasive lobular carcinoma

Phey Ming Yeap, Andrew Evans, Colin A. Purdie, Lee B. Jordan, Sarah J. Vinnicombe

Open Access Clinical trial

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study

Anna Sofie Kappel Buhl, Troels Dreier Christensen, Ib Jarle Christensen, Knud Mejer Nelausen, Eva Balslev, Ann Søegaard Knoop, Eva Harder Brix, Else Svensson, Vesna Glavicic, Adam Luczak, Sven Tyge Langkjer, Søren Linnet, Erik Hugger Jakobsen, Jurij Bogovic, Bent Ejlertsen, Annie Rasmussen, Anker Hansen, Steen Knudsen, Dorte Nielsen, Peter Buhl Jensen

Open Access Clinical trial

Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy

A. B. Sanchez-Spitman, V. O. Dezentjé, J. J. Swen, D. J. A. R. Moes, H. Gelderblom, Henk-Jan Guchelaar

Clinical trial

Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)

Anouk K. M. Claessens, Monique E. M. M. Bos, Marta Lopez-Yurda, Jeanette M. Bouma, Jeany M. Rademaker-Lakhai, Aafke H. Honkoop, Hiltje de Graaf, Edith van Druten, Laurence J. C. van Warmerdam, Maurice J. C. van der Sangen, Vivianne C. G. Tjan-Heijnen, Frans L. G. Erdkamp

Clinical trial

Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer

Eun Jin Song, Chan Wha Lee, So-Youn Jung, Byeong Nam Kim, Keun Seok Lee, Seeyoun Lee, Han-Sung Kang, In Hae Park, Moo Hyun Lee, Yun Ju Kim, Kyungran Ko, Sohee Kim, Byung-Ho Nam, Eun Sook Lee

Clinical trial

Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer

Soo Youn Bae, Seok Jin Nam, Yongsik Jung, Sae Byul Lee, Byung-Woo Park, Woosung Lim, Sung Hoo Jung, Hsien Wen Yang, Seung Pil Jung

Open Access Clinical trial

Impact of primary breast cancer therapy on energetic capacity and body composition

Tarah J. Ballinger, Anurag Reddy, Sandra K. Althouse, Emily M. Nelson, Kathy D. Miller, Jeffrey S. Sledge

Epidemiology

Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality

Shi-Yi Wang, Jessica B. Long, Brigid K. Killelea, Suzanne B. Evans, Kenneth B. Roberts, Andrea L. Silber, Amy J. Davidoff, Tannaz Sedghi, Cary P. Gross

Epidemiology

Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines

Anand K. Narayan, Elena B. Elkin, Constance D. Lehman, Elizabeth A. Morris

Epidemiology

NRF1 motif sequence-enriched genes involved in ER/PR −ve HER2 +ve breast cancer signaling pathways

Jairo Ramos, Jayanta Das, Quentin Felty, Changwon Yoo, Robert Poppiti, Donna Murrell, Paula J. Foster, Deodutta Roy

Epidemiology

Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI

Janice S. Sung, Adriana D. Corben, Jennifer D. Brooks, Marcia Edelweiss, Delia M. Keating, Christine Lin, Elizabeth A. Morris, Prusha Patel, Mark Robson, Meghan Woods, Jonine L. Bernstein, Malcolm C. Pike

Brief Report

Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val)

Emma Tudini, Setareh Moghadasi, Michael T. Parsons, Lizet van der Kolk, Ans M. W. van den Ouweland, Dieter Niederacher, Lídia Feliubadaló, Barbara Wappenschmidt, Amanda B. Spurdle, Conxi Lazaro

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.